Your browser doesn't support javascript.
loading
IL-12 and IL-23 pathway inhibition in inflammatory bowel disease.
Verstockt, Bram; Salas, Azucena; Sands, Bruce E; Abraham, Clara; Leibovitzh, Haim; Neurath, Markus F; Vande Casteele, Niels.
Afiliação
  • Verstockt B; University Hospitals Leuven, Department of Gastroenterology and Hepatology, KU Leuven, Leuven, Belgium.
  • Salas A; KU Leuven Department of Chronic Diseases and Metabolism, Translational Research Center for Gastrointestinal Disorders (TARGID), Leuven, Belgium.
  • Sands BE; Inflammatory Bowel Disease Unit, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Barcelona, Spain.
  • Abraham C; Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Leibovitzh H; Department of Medicine, Yale University, New Haven, CT, USA.
  • Neurath MF; Zane Cohen Centre for Digestive Diseases, Division of Gastroenterology & Hepatology, Temerty Faculty of Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Vande Casteele N; Department of Medicine 1, University Erlangen-Nürnberg, Erlangen, Germany.
Nat Rev Gastroenterol Hepatol ; 20(7): 433-446, 2023 07.
Article em En | MEDLINE | ID: mdl-37069321
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Crohn / Interleucina-12 Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Crohn / Interleucina-12 Idioma: En Ano de publicação: 2023 Tipo de documento: Article